The pioneer in the global digital therapeutics market, DarioHealth Corp. (DRIO) shares ended after-hours trading at $17.26 up 6.87%. At the close of business last session, DRIO stock increased 1.25% or $0.2 to $16.15. Over the course of the day, DarioHealth stock fluctuated between $15.70 and $16.43. In the regular session, DRIO shares changed hands for 0.19 million, lower than the 0.3 million volume for the 50 days prior and lower than its 0.28 million Year to Date volume.

DRIO stock has fallen 133.72% in the past 12 months, and it has fallen -16.67% in the last week. DRIO has lost -18.31% in the last six months and has lost -2.24% in the last three months. So far this year, shares have returned 13.02%. As a regional healthcare organization selected DRIO as a digital health provider, DRIO stock continued to rise.

What made them choose DRIO?

DarioHealth is a leading company in digital therapeutics that is revolutionizing the way chronic-ill patients manage their medical conditions. Digital therapeutics solutions from DRIOS are among the most comprehensive on the market – supporting the treatment of multiple chronic conditions, including diabetes, hypertension, weight management, musculoskeletal health, and behavioral health. A unique user-centric approach to product design and engagement makes DRIO products stand out from the competition and deliver results that customers can depend on.

Alabama Regional Medical Services (ARMS) selected DarioHealth as a digital health provider, announced DRIO in a press release yesterday.

• ARMS is a Federally Qualified Health Center (FQHC) in Jefferson, Shelby, St. Clair, and Blount counties, which is accredited by The Joint Commission as a Primary Care Medical Home.
• In regard to managing hypertension among a diverse patient population, including many underserved and uninsured individuals, ARMS selected DRIO’s Remote Patient Monitoring (RPM).
• The percentage of Alabamans with high blood pressure is over 40%, and those who live in lower-income neighborhoods tend to suffer worse outcomes.
• By partnering with DRIO, ARMS has access to innovative technologies and highly personalized support that engage patients, including those who have challenges utilizing technology.
• The contract represents DRIO’s second competitive win in the last month for its RPM division.

How is DRIO going to support ARMS?

With the DarioHealth (DRIO) RPM system, ARMS joins a growing number of providers and health systems that are seeking to address the stubborn challenge of engaging patients in improving their health and wellbeing. A key reason for ARMS’ selection of DRIO was its ability to customize its RPM solution to meet the unique clinical and financial goals of the organization while helping to meet the unique needs of the population.